Company / Cash per Share
Vir Biotechnology, Inc. Cash per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.70
FY2025
5-year range
$1.65 / $3.43
FY2021-FY2025
Trend
+2.5%
vs FY2024
Sector context
#116 of 205
Health Care
What the data says
At $1.70, Vir Biotechnology, Inc.'s cash per share ranks #116 of 205 in the Health Care sector. Cash per Share returned to growth in FY2025 after 5 years of decline, reaching $1.70.
Based on SEC 10-K filings.
1.70 in FY2025 with a 5-year CAGR of -16.0%.
Declined from $1.81 to $1.70 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -13.9%
- 5-Year CAGR
- -16.0%
- 10-Year CAGR
- -
Sector benchmark
#116 of 205 in Health CareTop 57% of 205This company $1.70 Sector average $72.93
▼
-97.7% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 2.5% year-over-year.
- Ranks #116 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2017.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.70 | +2.5% |
| FY2024 | $1.65 | -8.8% |
| FY2023 | $1.81 | -31.6% |
| FY2022 | $2.65 | -22.6% |
| FY2021 | $3.43 | -15.5% |
| FY2020 | $4.06 | -67.1% |
| FY2019 | $12.34 | +98.8% |
| FY2018 | $6.21 | -92.9% |
| FY2017 | $87.31 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026